Women's-health guide
Lighter You Review: A Real Operator With No Public Price
Lighter You names four pharmacies with street addresses and publishes no price you can verify. Its $99 headline buys nothing. What we found in August 2026.
On this page
Our pick for women
Grade ACoreAge Rx
93/100The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
Check availability- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
Also worth a look
System Labs
Grade B−A flat $179 a month at every dose, with the ongoing rate stated in writing rather than buried under an intro price — and you can cancel from your own dashboard, which is more than most of this ranking will commit to.
Visit System LabsLighter You (lighteryou.co) is a real telehealth operator that we cannot price. Those two statements sit together uncomfortably, and most reviews of a company like this resolve the discomfort by picking one and dropping the other. This one keeps both, because a reader deciding where to spend several hundred dollars a month needs to know that the company is genuine and that nothing it publishes about cost can be checked.
Start with what is real
Four dispensing pharmacies are named, each with a street address: Red Rock Home Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Compounding Pharmacy in Bellmore, New York; and Triad Rx in Daphne, Alabama. Telehealth consent is hosted by OpenLoop, an established clinical infrastructure company. The certification seal on the site verifies against the certifying body's own image host rather than being a picture uploaded to the company's own server. The legal pages are complete, and coverage is given as all 50 states and DC, with the caveat that some services may not be available everywhere.
That is a better pharmacy disclosure than most of the seven telehealth sellers we screened together in August 2026 manage, and it is the reason this review is not shorter. Naming the pharmacy that fills your vial is the check our checklist for judging a program before you pay puts first, and Lighter You passes it four times over.
Now the price surface
Everything Lighter You publishes about cost is seven fixed strings. A banner reads "starting at $99". The hero repeats "start for just $99". Three program cards read "starting at $169" for weight loss, "starting at $145" for peptides and longevity, and "starting at $169" for microdosing. The remaining two cards, men's health and women's health, read "membership plus medication cost" and carry no number at all.1
The $99 buys nothing. There is no $99 tier anywhere on the site; the cheapest program named is $145. It is a headline attached to no product — the same species of number as a first-order promotion presented as a standing rate, except that here there is no standing rate to compare it against.
And there is no way to check any of it. The "get started" button on every card routes to a page that requires an authenticated account. There is no public catalog, no product page, no checkout and no price-returning interface. The site's own sitemap contains six URLs in total — a homepage, an about page and four legal pages. There are no product pages because no products are published.
What is being sold is also unstated
One line in the FAQ is the only place the site says what molecules it works with: GLP-1 medications such as tirzepatide and semaglutide, targeted peptide therapies, and medications for men's and women's health. No peptide is ever named. No route, dose or formulation is stated anywhere.
For a reader treating insulin resistance, that is not a small omission. Whether you are being offered semaglutide or tirzepatide changes the mechanism — the second adds a gut-hormone pathway alongside GLP-1 and produced the largest average reductions in the obesity trials2 — and whether the product is compounded or branded changes what you are buying entirely, as our compounded versus brand-name guide sets out. Neither question has a published answer here, and a program built around monitoring should be able to say what it is monitoring; see our guide to labs and monitoring on GLP-1 for the baseline a real one starts from.
Two entities and two refund policies
The terms and privacy policy name Lighter You, LLC. The HIPAA notice names Lighter You Health, Inc. Two different operators appear across the same site's legal pages, and no address is published for either.
The FAQ promises a 30-day satisfaction guarantee. The refund policy contains no such guarantee and contradicts it in block capitals: other than cancellation due to medical disqualification, in no event shall a refund be issued upon cancellation. Canceling requires 72 hours' notice, and refunds, where they are issued at all, cover only the most recent billing cycle. You are charged for the first month when you complete the intake form, before a provider reviews it.
Set beside the pharmacy disclosure, that is a strange combination — a company careful enough to publish four dispensing addresses and careless enough to promise a guarantee its own policy denies.
The FDA screen
We queried the FDA's live warning-letter index in August 2026 for the brand, for its four named pharmacies and for its clinical partner. Nothing matched in the company column.3 One near miss is worth naming so the next reader does not record it wrongly: a company with a similar name holds a tobacco-related letter and is an entirely different business. As with the rest of this batch, the pass carried a positive control that returned correctly, so the zeros are evidence rather than silence.
Where it lands
Lighter You is not a shell, and it should not be described as one. It is a real operator with genuine pharmacy transparency whose entire commercial proposition sits behind a login — a second operator gates its figures behind a medical questionnaire instead, which is a different door onto the same room — with a headline price that matches nothing it sells and a refund promise its own policy revokes. On the three questions this site asks of a program — can you keep getting the medication, can you climb to an effective dose without a repricing, and can you stop without a penalty — the first two have no published answer and the third has two answers that contradict each other.
If the company later publishes product pages with per-molecule pricing, it is worth looking at again; the pharmacy disclosure is better than most of its peers'. Until then, read it against Auren Rx, which publishes every rung of every product, and against the rubric on our Luna Fit Score methodology page. Lighter You is not scored there: it is not in our ranking, we earn nothing from it, and this review exists because "starting at $99" deserved to be checked rather than repeated.
Frequently asked questions
How much does Lighter You cost?
It does not publish a price you can verify. Its public price surface is seven fixed strings: a $99 headline, three 'starting at' program figures of $169, $145 and $169, and two programs with no number at all. Every route to a real price requires an account.
Is the $99 on Lighter You's homepage a real price?
No program on the site costs $99. The cheapest program named is $145, and there is no $99 tier anywhere in the site's own data.
Does Lighter You offer a 30-day guarantee?
Its FAQ says so; its refund policy contradicts it in block capitals, stating that other than cancellation for medical disqualification, no refund shall be issued upon cancellation. Canceling requires 72 hours' notice and refunds cover only the most recent billing cycle.
Is Lighter You a legitimate company?
It is a real operator, not a shell. It names four dispensing pharmacies with street addresses, hosts telehealth consent through OpenLoop, carries a certification seal that verifies against the certifying body's own host, and publishes complete legal pages. Its problems are price transparency and two contradictory legal entities, not existence.
References
- Lighter You, LLC (2026). Programs and published pricing strings. lighteryou.co. https://lighteryou.co/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2206038
- U.S. Food and Drug Administration (2026). Warning Letters. FDA.gov. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Keep exploring
Trellis Vitality Review: One Complete Table, Four Blanks
Trellis publishes the best-formed GLP-1 price table of seven providers we screened — and four other programs with no ladder at all. Verified August 2026.
Read the guide →HumeCare+ review: it weighs the muscle
HumeCare+ ships a body analyzer with the medication and reads fat and lean mass weekly. It also publishes no price until you have finished the medical intake.
Read the guide →What GLP-1 Costs and How to Start Safely
A measured women's-lens look at GLP-1 cost and starting safely: 503A vs 503B pharmacies, LegitScript, FDA compounding and what to verify.
Read the guide →The Edit Review: $209 Semaglutide, Cancel Anytime
The Edit's semaglutide and tirzepatide ladder is the only one of seven we could not break on arithmetic. What we verified in August 2026, and what we could not.
Read the guide →Auren Rx Review: A Real Monthly Rung, an Unpublished Map
Auren Rx prints an explicit no-commitment rung on every product — then never says which states it serves. What we verified in August 2026, and the two traps.
Read the guide →Vyvron Review: Thirteen Charges a Year, Not Twelve
Vyvron bills every four weeks while printing '/mo', and has no monthly tirzepatide plan at all. The arithmetic, the disclosures it gets right, August 2026.
Read the guide →